Cancer Council Queensland, Brisbane, Queensland, Australia.
Cancer Council Queensland, Brisbane, Queensland, Australia; Griffith Health Institute, Griffith University, Gold Coast, Queensland, Australia; School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.
J Invest Dermatol. 2014 Dec;134(12):2883-2889. doi: 10.1038/jid.2014.266. Epub 2014 Jul 3.
The relatively high incidence of Merkel cell carcinoma (MCC) in Queensland provides a valuable opportunity to examine links with other cancers. A retrospective cohort study was performed using data from the Queensland Cancer Registry. Standardized incidence ratios (SIRs) were used to approximate the relative risk of being diagnosed with another primary cancer either following or prior to MCC. Patients with an eligible first primary MCC (n = 787) had more than double the expected number of subsequent primary cancers (SIR = 2.19, 95% confidence interval (CI) = 1.84-2.60; P<0.001). Conversely, people who were initially diagnosed with cancers other than MCC were about two and a half times more likely to have a subsequent primary MCC (n=244) compared with the general population (SIR = 2.69, 95% CI = 2.36-3.05; P<0.001). Significantly increased bi-directional relative risks were found for melanoma, lip cancer, head and neck cancer, lung cancer, myelodysplastic diseases, and cancer with unknown primary site. In addition, risks were elevated for female breast cancer and kidney cancer following a first primary MCC, and for subsequent MCCs following first primary colorectal cancer, prostate cancer, non-Hodgkin lymphoma, or lymphoid leukemia. These results suggest that several shared pathways are likely for MCC and other cancers, including immunosuppression, UV radiation, and genetics.
昆士兰州相对较高的 Merkel 细胞癌 (MCC) 发病率为研究与其他癌症的联系提供了一个有价值的机会。本研究采用昆士兰癌症登记处的数据进行了回顾性队列研究。采用标准化发病比 (SIR) 来估计在 MCC 后或前诊断出另一种原发性癌症的相对风险。符合条件的首发 MCC 患者 (n=787) 随后发生原发性癌症的数量超过预期 (SIR=2.19, 95%置信区间 (CI)=1.84-2.60; P<0.001)。相反,最初被诊断为非 MCC 癌症的人随后发生原发性 MCC 的可能性是一般人群的两倍半 (n=244) (SIR=2.69, 95%CI=2.36-3.05; P<0.001)。黑色素瘤、唇癌、头颈部癌症、肺癌、骨髓增生异常疾病和未知原发性部位的癌症的双向相对风险显著增加。此外,在首发 MCC 后女性乳腺癌和肾癌的风险增加,在首发结直肠癌、前列腺癌、非霍奇金淋巴瘤或淋巴样白血病后发生 MCC 的风险增加。这些结果表明,MCC 和其他癌症可能存在几个共同的途径,包括免疫抑制、紫外线辐射和遗传因素。